In connection with the annual I3LUNG meeting IHE participated in a conference on AI and cancer
Last week Michael Willis, research director at IHE, attended the third annual meeting for I3LUNG, An EU-funded Project fostering the implementation of artificial intelligence (AI)-based personalized medical care for lung cancer patients in which IHE is one of 16 partners.
In connection with the annual meeting, a 2-day conference was also organized on the subject of Artificial Intelligence in Oncology: Applications and challenges. Michael Willis was one of the participants and gave a presentation on the Ethical and Regulatory Environment of AI in Healthcare and the Impact to Patients from a Health Economics perspective.
